H8-A5 is a human histone deacetylase 8 (HDAC8) inhibitor with anti-proliferative activity in MDA-MB-231 cancer cells; it exhibits selectivity for HDAC8 over HDAC1/4 and serves as a promising lead compound for the development of HDAC8-targeted anticancer agents.